References
- Degott C, Messing B, Moreau D, Chazouillères O, Paris R, Collombel JF, et al. Liver phospholipidosis induced by parenteral nutrition: histologic, histochemical, and ultrastructural investigations. Gastroenterology 1988; 95: 183–91.
- Fréneaux E, Pessayre D. Drug-induced steatosis, phospholipidosis and alcohol-like liver injury. Gastroenterol Clin Biol 1993; 17: H36–43.
- Ogawa Y, Murata Y, Nishioka A, Inomata T, Yoshida S. Tamoxifen-induced fatty liver in patients with breast cancer. Lancet 1998; 351: 725.
- Westphal JF, Vetter D, Brogard JM. Hepatic side-effects of antibiotics. J Antimicrob Chemother 1994; 33: 387–401.
- Koeda T, Odaki M, Sasaki H, Yokota M, Watanabe H, Kawaoto H, et al. Toxicological studies on fosfomycin-Na salt. Jpn J Antibiot 1979; 32: 61–105.
- Colombo C, Apostolo MG, Assaiso M, Roman B, Bottani P. Liver disease in cystic fibrosis. Neth J Med 1992; 41: 119–22.
- Lindblad A, Glaumann H, Strandvik B. Natural history of liver disease in cystic fibrosis. Hepatology 1999; 30: 1151–8.
- Vawter GF, Schwachman H. Cystic fibrosis in adults: an autopsy study. Pathol Ann 1979; 14: 357–82.
- Durieu I, Pellet O, Simonot L, Durupt S, Bellon G, Vital Durand D, et al. Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic study. J Hepatol 1999; 30: 1052–6.